A soluble serotonin-binding protein was identified in a high-speed supernatant fraction of an osmotically shocked rat brain synaptosome (P2) preparation. The binding of serotonin was saturable (B. = 6.0 umol per mg of protein) and was specific for serotonin and a few structurally related compounds including dopamine and norepinephrine. Binding of serotonin (1 ,uM) was inhibited "40% by chlorpromazine (10 AuM). The affinity of serotonin for the binding protein was low in the crude extract (Kd = 1.7 X 10-3 M). However, on purification by chromatography on a column of phenothiazine agarose, a higher affinity (Kd = 10-5 M) binding component was also observed. The purified protein was greatly enriched in a polypeptide Of Mr of 43,000 that comigrated on polyacrylamide gel with skeletal muscle actin. Muscle actin also bound serotonin, and the binding to actin was similar to that of the purified protein in both the specificity of the binding and the affinity for serotonin. It is likely that the serotoninbinding protein is identical to cytoplasmic G-actin or an actinlike protein of similar molecular weight.
The release of neurotransmitters from nerve terminals is triggered by an increase in the intracellular concentration of Ca2+ ions [reviewed by Blaustein et al. (1) ]. The similarity between Ca2l-stimulated actomyosin interactions and neurotransmitter release mechanisms has prompted many investigators to suggest that actin and myosin may be directly involved in the release of some neurotransmitters (2) (3) (4) (5) (6) (7) (8) . Contractile processes in smooth muscle and nonmuscle cells are regulated by phosphorylation of the light chain of myosin by a Ca2+-calmodulin-dependent kinase (for review, see refs. 9 and 10). Phosphorylation of myosin converts it from a form that cannot be activated by actin to a form that can be activated. A similar mechanism might regulate the release of neurotransmitters (11) .
Contractile proteins are particularly enriched in nerve terminals. Synaptosomes contain both actin and myosin (3, 4) as well as a Ca2+-stimulated myosin-like ATPase activity, which is associated with synaptic vesicles (3) . Actin has been identified in highly purified synaptic vesicle preparations (12) and is also present, mainly as unpolymerized Gactin, within neuronal cytoplasm (13) .
Indirect evidence has been obtained for the involvement of actin and myosin in the release of neurotransmitters. Cytochalasin B, which binds to actin and inhibits its polymerization (14) , also inhibits the K+-stimulated release of catecholamines from synaptosomes (5) . The phenothiazine antipsychotic drug trifluoperazine, which inhibits phosphorylation of the myosin light chain, also inhibits the release of norepinephrine from chromaffin cells (11) . Electrically stimulated release of norepinephrine from sympathetic nerves can be blocked by cytochalasin B and by vinblastine, a compound that binds to tubulin (15) but may also interact with actin (16, 17) .
In this report, we show that a synaptosome-enriched pellet (P2) from rat brain contains an actin-like protein that binds serotonin (5HT) as well as the structurally related monoamines, dopamine and norepinephrine.
MATERIALS AND METHODS Materials. [1,2-3H(N) ]Serotonin creatinine sulfate (30 Ci/mmol; 1 Ci = 37 GBq) was purchased from New England Nuclear. Serotonin creatinine sulfate (nonradioactive), chlorpromazine hydrochloride, vinblastine sulfate, colchicine, L-tryptophan, tryptamine hydrochloride, 5-hydroxyindole-3-acetic acid, melatonin, dopamine hydrochloride, (-)-norepinephrine hydrochloride, 3,4-dihydroxyphenylacetic acid, homovanillic acid, rabbit muscle actin, and bovine serum albumin were all purchased from Sigma. Phenothiazine agarose was obtained from Bio-Rad; Sephadex G-150 and Sephadex G-50 (superfine) were from Pharmacia. All other chemicals used were of analytical reagent grade or of comparable purity.
SHT-Binding Assay. The binding of 5HT to soluble proteins was assayed at equilibrium. [3H]5HT (6 uCi; 1 ALM SHT) was incubated with protein (up to 200 pgg) for 1 hr at 370C in a total volume of 0.2 ml. The assay buffer was the same as that used during the purification of the 5HT-binding protein-i.e., either 20 mM potassium phosphate, pH 7.4/0.1 M potassium chloride (KP buffer) for studies on the crude P2 supernatant fraction, or 10 mM imidazole-HCl, pH 7.4/0.1 mM calcium chloride/0.5 mM dithiothreitol/0.5 mM ATP (imidazole buffer) for studies on either the purified binding protein or skeletal muscle actin. The incubation was terminated by cooling assay tubes at 40C for 1 min. As the 5HT-protein complex was found to be quite stable at 40C for up to 1 hr, it was possible to separate bound from free radioactivity by gel filtration chromatography. Aliquots (0.05 ml) from each tube were applied to the top of Sephadex G-50 (superfine) columns (1.1-ml gel bed volume in disposable polypropylene columns from Bio-Rad) equilibrated with assay buffer at 40C. Bound radioactivity was eluted from the columns directly into scintillation vials with 0.675 ml of assay buffer. The columns stopped flowing once the top of the eluent reached the top of the gel bed. Radioactivity eluted from the columns was assayed for 3H. The incubation was also run in parallel with tubes containing no protein. In the absence of protein, radioactivity eluting in the bound fraction (close to the void volume) was generally <0.005% of the total radioactivity in the incubation mixture. This radioactivity was subtracted from that measured in the presence of protein.
The amount of bound radioactivity was found to be directly proportional to the amount of protein in the incubation mixture up to 2.5 mg/ml. Incubation in the presence of increasing amounts of nonradioactive SHT led to complete loss of the bound radioactivity, indicating that all of the binding measured under these assay conditions was saturable. The equilibrium dissociation constant (Kd) and maximum binding capacity (Bmax) were determined using a computer program, directly fitting "bound vs. free" plots of the data to the hyperbolic equations (18) .
Purification of SHT-Binding Protein. The 5HT-binding protein was purified from osmotically shocked crude synaptosomal pellets (P2) obtained from rat brain. Twenty male rats (200-300 g; CD strain from Charles River Breeding Laboratories) were decapitated and a P2 pellet fraction was prepared by the method of Gray and Whittaker (19) . The pellets were osmotically shocked by mixing with 4 vol (-80 ml) of ice-cold distilled water, and then the mixture was centrifuged ( 3H (0.5-1.0 ml aqueous sample) was assayed at 33% efficiency in 10 ml of Aquasol-2 (New England Nuclear) using a Packard Tri-Carb liquid scintillation spectrometer. NaDodSO4/PAGE was carried out by the method of Fairbanks et al. (22) . Gels were stained with Coomassie brilliant blue G-250 and scanned for protein at 600 nm using a PerkinElmer 559 spectrophotometer. The binding affinity of SHT for soluble protein in the P2 supernatant fraction (Fig. 2a) was much lower (Kd = 1.7 x 10-3 in the absence of Fe2+) than that reported for membrane-bound SHT receptors (Kd = 1-10 X 10-9 M; see ref.
RESULTS
24). As the binding was saturable, it seemed unlikely that it represented a nonspecific interaction. The concentration of binding sites (6 nmol per mg of protein) was much greater than the corresponding concentration for SHT receptors (=100 fmol per mg of protein; see ref. 24) .
The specificity of the interaction of 5HT for this protein was examined by studying the ability of various indoles to compete for [3H]SHT-binding sites in the P2 supernatant fraction (Table 1) . Indoles (1 mM) were incubated with
[3H]5HT (at a concentration of 1 gM, incubated in the absence of Fe2+) and the amount of bound radioactivity was determined. SHT was the most potent inhibitor of binding; other indoles competed less effectively. SHTP also inhibited the binding. This was not due to metabolism of the SHTP to SHT during the incubation, as no SHT fluorescence could be detected in the 5HTP incubation mixtures after 1 hr using thin-layer chromatography. bind stereospecifically to the dopamine receptor and, at higher concentrations, also bind stereospecifically to the 5HT receptor (26) , inhibited [3HJ5HT binding by about 40%, at a concentration of 10 tLM. The strong binding of phenothiazines to the dopamine receptor is probably due to their structural similarity with dopamine (27) . The vinca alkaloid vinblastine, which contains two indole-like moieties (28), also strongly inhibited [3H]5HT binding at this concentration (Table 1) . However, colchicine, a hydrophobic drug that binds to the tnicrotubule protein tubulin (15, 29) but bears little resemblance to 5HT did not inhibit 5HT binding.
Purification. Advantage was taken of the interaction of the phenothiazine CPZ with the 5HT-binding site to purify the binding protein. The P2 supernatant fraction was passed across a column of phenothiazine agarose. After eluting traces of calmodulin with EGTA, the remaining bound protein was eluted with a pH 9.5 buffer. The Bma, for5HT binding to this fraction (in the absence of Fe2+) was 5-fold greater than to the P2 supernatant fraction (Fig. 2b) . NaDodSO4/ PAGE revealed that this fraction contained predominantly a protein of Mr 43,000 that comigrated with skeletal muscle actin (Fig. 3) . The total number of binding sites in the purified preparation was =1 mol per 43,000 g of protein (calculated from Fig. 2b ).
When the purified 5HT-binding protein was chromatographed on Sephadex G-150, a single major peak of protein was eluted from the column (Fig. 4) . This peak eluted in the same position as the single peak of [3H]SHT-binding activity and also in the same position as purified muscle G-actin.
Sinilarity of the Binding Protein to Actin. 5HT also bound to purified skeletal muscle actin (Fig. 2c) . In general, the specificity of the binding to actin, in terms of those compounds that inhibited the binding and those that did not, was similar to that of the purified binding protein and to that of the P2 supernatant fraction (Table 1) . Fe2+, an ion that has tCa, which was a normal constituent of the buffer used for studies of binding to the purified protein and muscle actin, was omitted from control incubations.
been reported to stimulate the binding of 5HT to a high-affinity 5HT-bindihg protein isolated by Tamir and co-workers (31) (32) (33) , also stimulated the binding of SHT to actin and to (22) . The gels were stained with Coomassie brilliant blue G-250 and destained as described by Fairbanks et al. (22) . Relative Scatchard plots (Fig. 2) showed that the affinity of 5HT for actin was similar to its affinity for the purified binding protein, although both preparations yielded nonlinear Scatchard plots. A higher-affinity binding component was evident in both fractions (Kd = 10-50 x 10-6 M). Incubation in the presence of 0.1 mM FeSO4 increased the size of this component, apparently by increasing the Bmax for the high-affinity interaction. It was not possible to determine from these experiments whether the high-affinity binding was to actin or to an actin contaminant present in both preparations. As the binding protein coeluted with skeletal muscle G-actin from the Sephadex G-150 column, the former possibility seems more likely.
Competition for SHT-Binding Sites. Fig. 5 shows the ability of CPZ, 5HT, and L-tryptophan to compete for 5HT binding to the purified preparation at various concentrations. Incubations were carried out in the presence of 0.1 mM FeSO4. Both CPZ and 5HT competed for binding with [3H]5HT. The inhibition-curves were complex; both high-affinity and lowaffinity binding were evident with both compounds. The results were consistent with the data from the Scatchard analysis, of binding (Fig. 2b) , as competition for binding by 5HT suggested a Kd of _10-5 M for the high-affinity component.
The specificity of the interaction of 5HT for the binding protein was evident from the fact that L-tryptophan, although structurally similar to 5HT, bound shown to be very similar in both molecular weight and amino acid composition to cytoplasmic actin isolated from mammalian brain (35) .
It is possible that both the high-affinity and the low-affinity binding of 5HT are associated with actin, because the purified skeletal muscle actin also bound 5HT with both highand low-affinity interactions. One explanation for these findings is that a small proportion of the actin molecules may exist in a high-affinity binding conformation. Actin may be present either in the polymerized F-actin form or in the unpolymerized G-actin form (36) . Its conformation in solution is regulated by several factors including ionic strength and the concentrations of ATP and divalent cations (36) . In vivo, actin may exist in a variety of different conformations, which may be regulated by numerous actin-binding proteins (34). However, we cannot rule out the possibility that the highand low-affinity binding may involve two different proteins.
Tamir and co-workers have described a Fe2+-stimulated 5HT-binding protein in rat brain (31) (32) (33) . Although this protein (SBP) has also been suggested as being actin-like in its properties (37) , it is reported to have a low Kd for 5HT (101 to 10-8 M; see ref. 32 ) and an apparent Mr on NaDodSO4/ PAGE of about 60,000 (32) . We have been unable to show such high-affinity binding in our preparations. SBP has been purified 100-fold from a rat brain supernatant fraction by a combination of procedures involving ammonium sulfate precipitation and molecular sieve chromatography (33) . Until this protein is completely purified, it will be difficult to determine whether it is similar to cytoplasmic actin. The fact that SBP possesses a different molecular weight from actin would argue in favor of its being a distinct protein. Furthermore, SBP has been reported (38) as being localized within synaptic vesicles of 5HT neurons. As the Fe2 -stimulated binding in the present study was also observed in association with a purified muscle actin preparation, it is clearly not associated solely with 5HT neurons.
5HT is synthesized in the cytoplasm of serotoninergic neurons. Some of the 5HT may be taken up into synaptic vesicles by an active uptake process (39) . As the total 5HT concentration within serotoninergic nerve terminals is probably very high (50-100 mM; see ref. 40) , it seems likely that cytQplasmic 5HT levels may also be quite high. Freedman (41) has suggested that as much as 70-80%,of the 5HT in isolated rat brain synaptosomes may be in a nonvesicular cytoplasmic pool. Thus, a cytoplasmic protein that binds 5HT would be expected to possess a high Kd for SHT binding. Unlike receptor proteins, whichimust bind 5HT at relatively low concentrations, a millimolar Kd would be quite consistent with the anticipated function of a cytoplasmic protein. It has been suggested that in receptor binding studies low-affinity binding is difficult to measure because of the rapid rate at which ligands dissociate from low-affinity proteins (42) . This need be true only when the association rate constant (k1) is large, as in the case of receptor binding proteins (42) . The k1 for association of 5HT to the actin-like protein described in this study (k1 = 1.0 M-sect, calculated from the data in The stability of the 5HT-actin complex suggests that the binding of 5HT to actin may not be primarily a mechanism for storing the neurotransmitter awaiting release, because dissociation of 5HT from such storage sites must follow very rapidly on membrane depolarization (1 
